Pancreatic Neuroendocrine Tumor G2
specificA well-differentiated, intermediate-grade neuroendocrine neoplasm that arises from the pancreas. The mitotic count is 2-20 per 2 mm2 and/or the Ki-67 index is 3 to 20%.
39
Centers
1
Active Trials
—
Cancer Funding
Top Centers for Pancreatic Neuroendocrine Tumor G2(39)
Ranked by research excellence score (trials · grants · publications). Methodology →
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →